Cortisol and polycystic ovarian syndrome – a systematic search and meta-analysis of case–control studies

References

• Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–284.
   PubMed Web of Science ®Google Scholar
• Bharathi RV, Swetha S, Neerajaa J, et al. An epidemiological survey: effect of predisposing factors for PCOS in Indian urban and rural population. Middle East Fertil Soc J. 2017;22(4):313–316.
   Web of Science ®Google Scholar
• Daniilidis A, Dinas K. Long term health consequences of polycystic ovarian syndrome: a review analysis. Hippokratia. 2009;13(2):90–92.
   PubMed Web of Science ®Google Scholar
• Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37(5):467–520.
   PubMed Web of Science ®Google Scholar
• Pasquali R, Gambineri A. Cortisol and the polycystic ovary syndrome. Expert Rev Endocrinol Metab. 2012;7(5):555–566.
   PubMedGoogle Scholar
• Zangeneh FZ, Jafarabadi M, Naghizadeh MM, et al. Psychological distress in women with polycystic ovary syndrome from Imam Khomeini Hospital. J Reprod Infertil. 2012;13(2):111–115.
   PubMedGoogle Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (Reprinted from Annals of Internal Medicine). Phys Ther. 2009;89(9):873–880.
   PubMed Web of Science ®Google Scholar
• Bouhassira EE. The SAGE encyclopedia of stem cell research. Thousand Oaks (CA): Sage Publications; 2015.
   Google Scholar
• Hernandez AV, Guarnizo M, Miranda Y, et al. Association between insulin resistance and breast carcinoma: a systematic review and meta-analysis. PLoS One. 2014;9(6):e99317.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trial. 1986;7(3):177–188.
   PubMedGoogle Scholar
• Borenstein M, Higgins JP. Meta-analysis and subgroups. Prev Sci. 2013;14(2):134–143.
   PubMed Web of Science ®Google Scholar
• Rao G, Lopez-Jimenez F, Boyd J, et al. Methodological standards for meta-analyses and qualitative systematic reviews of cardiac prevention and treatment studies: a scientific statement from the American Heart Association. Circulation. 2017;136(10):e172–e194.
   PubMed Web of Science ®Google Scholar
• Begg CB. A comparison of methods to detect publication bias in meta‐analysis by P. Macaskill, SD Walter and L. Irwig, Statistics in Medicine, 2001; 20: 641–654. Stat Med. 2002;21(12):1803–1803.
   Google Scholar
• Basu BR, Chowdhury O, Saha SK. Possible link between stress-related factors and altered body composition in women with polycystic ovarian syndrome. J Hum Reprod Sci. 2018;11(1):10.
   PubMedGoogle Scholar
• Shabir I, Ganie MA, Praveen EP, et al. Morning plasma cortisol is low among obese women with polycystic ovary syndrome. Gynecol Endocrinol. 2013;29(12):1045–1047.
   PubMed Web of Science ®Google Scholar
• Arikan S, Akay H, Bahceci M, et al. The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrome patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function. Fertil Steril. 2009;91(2):450–455.
   PubMed Web of Science ®Google Scholar
• Ferrari E, Bossolo PA, Foppa S, et al. Prolactin secretion in polycystic ovary syndrome: circadian rhythmicity and dynamic aspects. Gynecol Endocrinol. 1988;2(2):101–111.
   PubMed Web of Science ®Google Scholar
• Gambineri A, Vicennati V, Genghini S, et al. Genetic variation in 11β-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(6):2295–2302.
   PubMed Web of Science ®Google Scholar
• Glintborg D, Altinok M, Mumm H, et al. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome. Hum Reprod. 2014;29(8):1773–1779.
   PubMed Web of Science ®Google Scholar
• Grimmichova T, Vrbíková, J, Matucha P et al. Fasting insulin pulsatile secretion in lean women with polycystic ovary syndrome. Physiol Res. 2008;57(1):S91–S98.
   PubMedGoogle Scholar
• Guido M, Ciampelli M, Fulghesu AM, et al. Influence of body mass on the hypothalamic-pituitary-adrenal–axis response to naloxone in patients with polycystic ovary syndrome. Fertil Steril. 1999;71(3):462–467.
   PubMed Web of Science ®Google Scholar
• Guven S, Karahan SC, Bayram C, et al. Elevated concentrations of serum ischaemia-modified albumin in PCOS, a novel ischaemia marker of coronary artery disease. Reprod Biomed Online. 2009;19(4):493–500.
   PubMed Web of Science ®Google Scholar
• Hahn S, Haselhorst U, Quadbeck B, et al. Decreased soluble leptin receptor levels in women with polycystic ovary syndrome. Eur J Endocrinol. 2006;54(2):287–294.
   Google Scholar
• Invitti C, De Martin M, Delitala G, et al. Altered morning and nighttime pulsatile corticotropin and cortisol release in polycystic ovary syndrome. Metabolism. 1998;47(2):143–148.
   PubMed Web of Science ®Google Scholar
• Kale-Gurbuz T, Akhan SE, Bastu E, et al. Adiponectin, leptin and ghrelin levels in obese adolescent girls with polycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2013;26(1):27–30.
   PubMed Web of Science ®Google Scholar
• Khashchenko E, Uvarova E, Vysokikh M, et al. The relevant hormonal levels and diagnostic features of polycystic ovary syndrome in adolescents. J Clin Med. 2020;9(6):1831.
   Web of Science ®Google Scholar
• Kiałka M, Milewicz T, Spałkowska M, et al. β-endorphins plasma level is higher in lean polycystic ovary syndrome (PCOS) women. Exp Clin Endocrinol Diabetes. 2016;124(01):55–60.
   PubMedGoogle Scholar
• Kiałka M, Ociepka A, Milewicz T, et al. Evening not morning plasma cortisol level is higher in women with polycystic ovary syndrome. Przegl Lek. 2015;72(5):240–242.
   PubMedGoogle Scholar
• Macut D, Vojnović Milutinović D, Božić I, et al. Age, body mass index, and serum level of DHEA-S can predict glucocorticoid receptor function in women with polycystic ovary syndrome. Endocr. 2010;37(1):129–134.
   Google Scholar
• Maidana P, Fritzler A, Mocarbel Y, et al. Association between vitamin D and adrenal parameters with metabolic and inflammatory markers in polycystic ovary syndrome. Sci Rep. 2019;9(1):1–6.
   PubMedGoogle Scholar
• Mitkov M, Pehlivanov B, Orbetzova M. Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters. Gynecol Endocrinol. 2008;24(11):625–630.
   PubMed Web of Science ®Google Scholar
• Olszanecka-Glinianowicz M, Banaś M, Zahorska-Markiewicz B, et al. Is the polycystic ovary syndrome associated with chronic inflammation per se? Eur J Obstet Gynecol Reprod Biol. 2007;133(2):197–202.
   PubMed Web of Science ®Google Scholar
• Özçaka Ö, Buduneli N, Ceyhan BO, et al. Is interleukin‐17 involved in the interaction between polycystic ovary syndrome and gingival inflammation? J Periodontol. 2013;84(12):1827–1837.
   PubMed Web of Science ®Google Scholar
• Özcan A, Yücel A, Noyan V, et al. Total and lipid bound sialic acid levels in patients with polycystic ovary syndrome. J Turk Ger Gynecol Assoc. 2012;13(2):79.
   PubMedGoogle Scholar
• Poison DW, Reed MJ, Scanlon MJ, et al. Androstenedione concentrations following dexamethasone suppression: correlation with clomiphene responsiveness in women with polycystic ovary syndrome. Gynecol Endocrinol. 1988;2(3):257–264.
   PubMed Web of Science ®Google Scholar
• Puurunen J, Piltonen T, Jaakkola P, et al. Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94(6):1973–1978.
   PubMed Web of Science ®Google Scholar
• Reinehr T, Kulle A, Rothermel J, et al. Longitudinal analyses of the steroid metabolome in obese PCOS girls with weight loss. Endocr Connect. 2017;6(4):213–224.
   PubMed Web of Science ®Google Scholar
• Roelfsema F, Kok P, Pereira AM, et al. Cortisol production rate is similarly elevated in obese women with or without the polycystic ovary syndrome. J Clin Endocrinol Metab. 2010;95(7):3318–3324.
   PubMed Web of Science ®Google Scholar
• Sahin Y, Kelestimur F. The frequency of late-onset 21-hydroxylase and 11 beta-hydroxylase deficiency in women with polycystic ovary syndrome. Eur J Endocrinol. 1997;137(6):670–674.
   PubMed Web of Science ®Google Scholar
• Terzieva DD, Orbetzova MM, Mitkov MD, et al. Serum melatonin in women with polycystic ovary syndrome. Folia Med. 2013;55(2):10–15.
   Google Scholar
• Vidal-Puig A, Muñoz-Torres M, Jodar-Gimeno E, et al. Hyperinsulinemia in polycystic ovary syndrome: relationship to clinical and hormonal factors. Clin Investig. 1994;72(11):853–857.
   PubMedGoogle Scholar
• Watrowski R, Rohde A, Maciejewska-Jeske M, et al. Hormonal and psychosocial correlates of psychological well-being and negative affectivity in young gynecological-endocrinological patients. Gynecol Endocrinol. 2016;32(1):21–24.
   PubMed Web of Science ®Google Scholar
• Vrbíklová J, Hill M, Stárka L, et al. An analysis of the relationship between insulin resistance and the activity of steroid C17,20-lyase and 3beta-hydroxysteroid dehydrogenase in ovaries and adrenals in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2000;108(7):455–462.
   PubMed Web of Science ®Google Scholar
• Prelević G, Würzburger M, Balint-Perić L. 24-hour serum cortisol profiles in women with polycystic ovary syndrome. Gynecol Endocrinol. 1993;7(3):179–184.
   PubMed Web of Science ®Google Scholar
• Mezzullo M, Fanelli F, Di Dalmazi G, et al. Salivary cortisol and cortisone responses to short-term psychological stress challenge in late adolescent and young women with different hyperandrogenic states. Psychoneuroendocrinology. 2018;91:31–40.
   PubMed Web of Science ®Google Scholar
• Tock L, Carneiro G, Pereira AZ, et al. Adrenocortical production is associated with higher levels of luteinizing hormone in nonobese women with polycystic ovary syndrome. Int J Endocrinol. 2014;2014:620605.
   PubMed Web of Science ®Google Scholar
• Gourgari E, Lodish M, Keil M, et al. Bilateral adrenal hyperplasia as a possible mechanism for hyperandrogenism in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2016;101(9):3353–3360.
   PubMed Web of Science ®Google Scholar
• Pasquali R, Patton L, Pocognoli P, et al. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92(11):4208–4217.
   PubMed Web of Science ®Google Scholar
• Kamel N, Tonyukuk V, Emral R, et al. The prevalence of late onset congenital adrenal hyperplasia in hirsute women from Central Anatolia. Endocr J. 2003;50(6):815–823.
   PubMed Web of Science ®Google Scholar
• Conrad CD, Mauldin-Jourdain ML, Hobbs RJ. Metyrapone reveals that previous chronic stress differentially impairs hippocampal-dependent memory. Stress. 2001;4(4):305–318.
   PubMedGoogle Scholar
• Deak T, Quinn M, Cidlowski JA, et al. Neuroimmune mechanisms of stress: sex differences, developmental plasticity, and implications for pharmacotherapy of stress-related disease. Stress. 2015;18(4):367–380.
   PubMed Web of Science ®Google Scholar
• Papalou O, Diamanti-Kandarakis E. The role of stress in PCOS. Expert Rev Endocrinol Metab. 2017;12(1):87–95.
   PubMed Web of Science ®Google Scholar
• Saxena R, Georgopoulos NA, Braaten TJ, et al. Han Chinese polycystic ovary syndrome risk variants in women of European ancestry: relationship to FSH levels and glucose tolerance. Hum Reprod. 2015;30(6):1454–1459.
   PubMed Web of Science ®Google Scholar
• Barra R, Cruz G, Mayerhofer A, et al. Maternal sympathetic stress impairs follicular development and puberty of the offspring. Reproduction. 2014;148(2):137–145.
   PubMed Web of Science ®Google Scholar
• Yildiz BO, Azziz R. The adrenal and polycystic ovary syndrome. Rev Endocr Metab Disord. 2007;8(4):331–342.
   PubMed Web of Science ®Google Scholar